Abstract
The pain associated with frequent secondary bone involvement can negatively affect the quality of life of patients affected by metastatic prostate cancer. Its proper diagnostic framework is important to optimize the treatment. We describe the case of a patient suffering from breaktrough cancer pain treated with sublingual fentanyl.
MeSH terms
-
Adenocarcinoma / pathology
-
Administration, Sublingual
-
Analgesics, Opioid / administration & dosage*
-
Bone Neoplasms / complications
-
Bone Neoplasms / secondary
-
Breakthrough Pain / drug therapy
-
Breakthrough Pain / etiology*
-
Cancer Pain / drug therapy*
-
Fentanyl / administration & dosage*
-
Humans
-
Male
-
Middle Aged
-
Prostatic Neoplasms / pathology
-
Quality of Life
Substances
-
Analgesics, Opioid
-
Fentanyl